First author (year of publication) | Country | Study design | Screening components | Sample | Male (%) | Age (years) | Risk of bias score |
Asif (2014)9 | USA | Non-randomised controlled trial | History, physical, ECG | High school athletes (n=952) | 50 | 15.5 | 8* |
Asif (2015)5 | USA | Cross-sectional | History, physical, ECG | High school athletes (n=1516) | 59 | 15.6 | 7–8 |
Asif (2015)11 | USA | Qualitative | Not specified | High school and collegiate athletes diagnosed with cardiac condition (n=25) | 52 | 17.7* | 8† |
Asif (2017)29 | USA | Cross-sectional | History, physical, ECG | Collegiate athletes (n=1192) | 55 | 19.0* | 8 |
Morrison (2020)30 | Canada | Cross-sectional | History, physical, ECG | Masters athletes (≥35 years) diagnosed with CVD (n=67) | 90 | 60.1 | 7 |
Schurink (2017)31 | Netherlands | Cross-sectional | History, physical, ECG, cardiac CT | Masters athletes (≥45 years) (n=275) | 100 | 54.5 | 7–8 |
Solberg (2012)39 | Norway | Cross-sectional | History, physical, ECG, echocardiography | Professional athletes (n=441) | 100 | 26.0 | 6 |
Tischer (2016)40 | Denmark | Cross-sectional | History, physical, ECG, echocardiography | Professional athletes (n=516) | 59 | 21.6 | 6–8 |
Age (years) is reported as mean or *median.
*Evaluated using Joanna Briggs Institute Checklist for Quasi-Experimental Studies (Non-Randomized Experimental Studies).
†Evaluated using Joanna Briggs Institute Checklist for Qualitative Research.
CVD, cardiovascular disease.